Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics | $6.01 | $3.24 | 1.17% | 100.1M | $67.7M | $1.47$15.49 |
| KZR | Kezar Life Sciences | $6.36 | $2.19 | 0.53% | 5.9M | $30.5M | $3.53$8.45 |
| NUAI | New Era Energy & Digital, Inc. | $4.55 | $1.4 | 44.44% | - | - | - |
| CREV | Carbon Revolution Public Limited Ordinary Shares | $5.34 | $1.62 | 43.36% | - | - | - |
| VHC | VirnetX | $23.87 | $6.87 | 0.40% | 2.3M | $72.6M | $3.68$29 |
| NXTC | NextCure | $11.93 | $3.23 | 0.37% | 438.2K | $23.3M | $2.69$19.2 |
| ACHV | Achieve Life Sciences | $4.2 | $1.12 | 0.36% | 15.9M | $157.4M | $1.84$5.31 |
| SGHT | Sight Sciences | $4.69 | $1.24 | 0.36% | 1.6M | $180.7M | $2.03$6.08 |
| ELBM | Electra Battery Materials Corporation | $2.22 | $0.58 | 35.37% | - | - | - |
| ADXN | Addex Therapeutics | $10.95 | $2.42 | 0.28% | 283K | $7.9M | $6.51$12.05 |
Related Articles
Featured Article
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Leo Miller|Aug 29, 2024
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?
Alex Carchidi|Apr 20, 2023
Atai's stock is hurting, but its pipeline is still packed with promising programs.
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic
George Budwell|Feb 9, 2023
Wall Street is bullish on these two beaten-down healthcare stocks.
New Regulations for Psychedelics? Here's What Investors Need to Know
Alex Carchidi|Jul 22, 2022
There are a couple of proposed regulations and policies in the pipeline.
3 Growth Stocks That Could 3x or More in 2022
Rich Duprey|Apr 20, 2022
The three stocks have been beaten down, but Wall Street still sees tremendous upside ahead.
Here's What Investors Need to Know About Sight Sciences Stock
Rachel Warren and Asit Sharma|Jan 12, 2022
The company is a newer player in the medical devices space.
Should Investors Consider Sight Sciences Stock?
Rachel Warren, Jason Hall, and Asit Sharma|Jan 10, 2022
The company recently became publicly traded.
These 4 Psychedelic Biotech Stocks Are Leading the Pack
Alex Carchidi|Oct 26, 2021
Their clinical programs and research-enabling technologies both surpass the competition.
4 Green Flags for Psychedelic Drug Stocks
Alex Carchidi|Jul 15, 2021
It's never been a better time to be a biotech developing psychedelic therapies.
Got $1,000? Consider This Freshly IPO'd Psychedelic Biotech
Alex Carchidi|Jul 3, 2021
It's off to a running start.
